Drug
Sodium Fluorescein
Sodium Fluorescein is a pharmaceutical drug with 6 clinical trials. Historical success rate of 80.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
80.0%
Based on 4 completed trials
Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
125%(5 trials)
Terminated
1(17%)
Phase Distribution
Ph phase_4
1
17%
Ph not_applicable
3
50%
Ph phase_3
2
33%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution6 total trials
Phase 3Large-scale testing
2(33.3%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
3(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
66.7%
4 of 6 finished
Non-Completion Rate
33.3%
2 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(4)
Terminated(2)
Detailed Status
Completed4
Terminated1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
80.0%
Most Advanced
Phase 4
Trials by Phase
Phase 32 (33.3%)
Phase 41 (16.7%)
N/A3 (50.0%)
Trials by Status
completed467%
terminated117%
withdrawn117%
Recent Activity
0 active trials
Showing 5 of 6
terminatednot_applicable
Sodium Fluorescein-Guided Resection of Pediatric Neurosurgical Tumors
NCT03752203
withdrawnnot_applicable
Intravenous Sodium Fluorescein Versus Oral Phenazopyridine for Ureteral Patency
NCT02757417
completedphase_3
Safety of Brimonidine Tartrate Ophthalmic Solution in a Population of Pediatric, Adult, and Geriatric Participants
NCT01959243
completedphase_3
Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Participants With Ocular Redness
NCT01959230
completednot_applicable
Evaluation of Ureteral Jets on Cystoscopy
NCT02476448
Clinical Trials (6)
Showing 6 of 6 trials
NCT03752203Not Applicable
Sodium Fluorescein-Guided Resection of Pediatric Neurosurgical Tumors
NCT02757417Not Applicable
Intravenous Sodium Fluorescein Versus Oral Phenazopyridine for Ureteral Patency
NCT01959243Phase 3
Safety of Brimonidine Tartrate Ophthalmic Solution in a Population of Pediatric, Adult, and Geriatric Participants
NCT01959230Phase 3
Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Participants With Ocular Redness
NCT02476448Not Applicable
Evaluation of Ureteral Jets on Cystoscopy
NCT02677623Phase 4
Evaluation of Ureteral Patency in the Post-indigo Carmine Era
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6